Site 1022 Liver Institute Northwest — Seattle, Washington

Site 1022 Liver Institute Northwest is a clinical research site located in Seattle, Washington, United States 98105.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 1022 Liver Institute Northwest has participated in 1 clinical trials.

Therapeutic areas: NASH - Nonalcoholic Steatohepatitis.

Sponsors: Terns, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 1022 Liver Institute Northwest?

Site 1022 Liver Institute Northwest has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 1022 Liver Institute Northwest conducted?

Site 1022 Liver Institute Northwest has 1 clinical trials on record. Their work covers NASH - Nonalcoholic Steatohepatitis.

Is Site 1022 Liver Institute Northwest accredited by Crixeo Health?

Site 1022 Liver Institute Northwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 1022 Liver Institute Northwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.